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Universite´ de Strasbourg/CNRS, UMR7177, Institut de Chimie, Strasbourg, FranceABSTRACT The very amino-terminal domain of the huntingtin protein is directly located upstream of the protein’s polyglut-
amine tract, plays a decisive role in several important properties of this large protein and in the development of Huntington’s
disease. This huntingtin 1–17 domain is on the one hand known to markedly increase polyglutamine aggregation rates and
on the other hand has been shown to be involved in cellular membrane interactions. Here, we determined the high-resolution
structure of huntingtin 1–17 in dodecyl phosphocholine micelles and the topology of its helical domain in oriented phosphatidyl-
choline bilayers. Using two-dimensional solution NMR spectroscopy the low-energy conformations of the polypeptide were
identified in the presence of dodecyl phosphocholine detergent micelles. In a next step a set of four solid-state NMR angular
restraints was obtained from huntingtin 1–17 labeled with 15N and 2H at selected sites. Of the micellar ensemble of helical con-
formations only a limited set agrees in quantitative detail with the solid-state angular restraints of huntingtin 1–17 obtained in
supported planar lipid bilayers. Thereby, the solid-state NMR data were used to further refine the domain structure in phospho-
lipid bilayers. At the same time its membrane topology was determined and different motional regimes of this membrane-
associated domain were explored. The pronounced structural transitions of huntingtin 1–17 upon membrane-association result
in a a-helical conformation from K6 to F17, i.e., up to the very start of the polyglutamine tract. This amphipathic helix is aligned
nearly parallel to the membrane surface (tilt angle ~77) and is characterized by a hydrophobic ridge on one side and an
alternation of cationic and anionic residues that run along the hydrophilic face of the helix. This arrangement facilitates
electrostatic interactions between huntingtin 1–17 domains and possibly with the proximal polyglutamine tract.INTRODUCTIONThe occurrence and onset of Huntington’s disease are corre-
lated with structural modifications within the amino-
terminal region of the huntingtin protein (1–4). Genetic
analysis of this hereditary disease identified the switch
from the healthy to the pathogenic state when at least one
allele encodes for more than 37 CAG repeats resulting in
expanded polyglutamine tracts for mutated huntingtin.
Similar observations have been made with other polyglut-
amine-related disorders (1), and it is thought that perturba-
tions of neuronal membranes caused by such extended
polyglutamine domains are responsible for the multiple
symptoms of Huntington’s disease. The pathogenesis of
Huntington’s disease has been associated with mitochon-
drial dysfunction (5,6) and the dysregulation of calcium
hemostasis (7), among other cell biological alterations.
Importantly, huntingtin or fragments thereof are involved
in a number of membrane-associated processes including
intracellular vesicle trafficking (8), and these proteins haveSubmitted April 25, 2013, and accepted for publication June 17, 2013.
6Matthias Michalek and Evgeniy S. Salnikov contributed equally to this
work.
*Correspondence: bechinger@unistra.fr
Abbreviations used: CD, circular dichroism; DPC, dodecyl phosphocho-
line; HFIP, 1,1,1,3,3,3-hexafluoro-2-propanol; NES, nuclear export
sequence; NOESY, nuclear Overhauser effect spectroscopy; POPC,
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; TFA, trifluoroacetic
acid; SDS, sodium dodecylsulfate; TFE, trifluoroethanol; TOCSY, total
correlation spectroscopy.
Editor: Klaus Gawrisch.
 2013 by the Biophysical Society
0006-3495/13/08/0699/12 $2.00been shown to be associated with the endoplasmic reticulum
(ER), the Golgi-apparatus, and endosomal vesicles (7,9).
Huntingtin is involved in vesicular trafficking along micro-
tubules (10–12), the formation of autophagic vacuoles (9),
and has been found to interact with F-actin through its first
14 amino- acid residues (13). It is essential for ER mainte-
nance (14,15) and a transcriptional regulator of REST/
NRSF response genes (16). The protein is found in dynamic
exchange between the late ER, the cytoplasm, and the
nucleus (9). Huntingtin is targeted to the ER membrane by
its first 17 amino acids(In previous publications reference
was made to the huntingtin 1–17 domain as N17 or
Htt17.) but this localization is in competition with transloca-
tion to the nucleus that occurs when the ER interactions are
weakened such as upon stress (9). Export of huntingtin from
the nucleus is mediated via NESs. One of them has been
identified within the same first 17 residues of its amino-
terminus (17,18), whereas others using different interaction
partners are located further downstream in the sequence
(19). Biochemical analysis indicates that nuclear export
through the huntingtin 1–17 domain occurs through interac-
tions with exportin 1 in a Ran-dependent manner (17,18).
Notably, the cellular localization of huntingtin is heavily
influenced by its first 17 amino acids (7) and to interact with
membranes in vivo huntingtin requires these amino-terminal
residues directly preceding the polyglutamine region (7,9).
In particular, huntingtin 1–17 has been shown to be involved
in huntingtin membrane interactions when at the same time
this domain is known to interact with itself as well as withhttp://dx.doi.org/10.1016/j.bpj.2013.06.030
700 Michalek et al.polyglutamines (20). Importantly, the presence of huntingtin
1–17 enhances polyglutamine aggregation (7,9,20–22), and
polyglutamine has been shown to interact with itself,
huntingtin 1–17 as well as with other proteins (22–25). As
a consequence, the resulting perturbations in protein struc-
ture have been suggested to initiate polyglutamine oligo-
merization in a manner that strongly depends on the
number of this amino acid making up the tract. Thereafter,
the polyglutamines assemble into stable fibrillar structures,
which form the nucleus for additional aggregation processes
(23–25).
Although mutagenesis, cell biological, in vivo, and
biophysical experiments all point to an important role of
huntingtin 1–17 in the membrane targeting and interactions
of huntingtin (7,9,26–30), very little data exists character-
izing the huntingtin 1–17 structure in membranes. In partic-
ular, knowledge of the structure of the huntingtin 1–17
domain in membranes promises to increase our understand-
ing not only of its interactions and properties within such
environments but also to shed light on its capacity to self-
associate and to interact with other proteins. This prompted
us to determine the membrane structure of huntingtin 1–17
by a combination of two-dimensional (2D) solution- and
solid-state NMR spectroscopies.
Whereas solution NMR spectroscopy is a well-estab-
lished technique to investigate the structure and dynamics
of peptides and proteins in isotropic environments, solid-
state NMR is a powerful method to study peptides and
proteins associated with lipid bilayers (31–34). Although
solid-state NMR angular constraints have the potential for
a full structure determination of membrane-associated poly-
peptides (35), this can become a time-consuming and
expensive task. Therefore, we chose an alternative approach
where we quantitatively tested a number of structural
models against a set of solid-state NMR angular constraints.
In a first step the qualitative agreement between the micellar
and the bilayer structures was evaluated by analyzing if the
solid-state NMR spectra of five 2H and 15N labeled sites
spread over the sequence (cf. Methods section) match the
outlines of the secondary structure elements observed in
the presence of DPC. The most stringent test arose from res-
idues, which are close to or define the ends of the huntingtin
1–17 helical domain. In a second step the angular restraints
obtained from the structured region of the peptide reconsti-
tuted in oriented phospholipid bilayers were compared in a
quantitative manner to the conformational ensemble
observed in micellar environments (i.e., from the labeled
sites 15N-Leu7, 2H3-Ala
10, 15N-Phe11, and 15N-Phe17). By
combining solution and solid-state NMR data in a novel
manner it was thus possible not only to validate the micellar
conformation in the context planar lipid bilayers and to
refine the structure by additional angular restraints but at
the same time to also consider peptide motions.
This work thereby complements a previous analysis
where the lipid-dependence of the huntingtin 1–17 mem-Biophysical Journal 105(3) 699–710brane interactions were investigated (30). Whereas in this
prior work the membrane-association and pore-forming
capacities of huntingtin 1–17 were quantitatively analyzed
as a function of lipid composition; here, we describe and
discuss the high-resolution NMR structure of the mem-
brane-associated domain in quantitative detail. Although
the membrane-partitioning constants and -activities have
been found to be strongly dependent on lipid composition,
the membrane topology of the membrane-associated
huntingtin 5–17 helical domain in pure phospholipid bila-
yers appears to be quite stable when a set of chemical shifts
and quadrupolar splittings are compared to each other as a
function of lipid composition (30). Whereas in this previous
work the pore-forming activities and CD-spectra were
obtained from the native huntingtin 1–17 peptides also
used here, much of the previous solid-state NMR data
were obtained from a peptide carrying an additional proline
at the amino-terminus (P-huntingtin 1–17). Importantly,
when the same labeled sites are compared to each other
similar solid-state spectra were obtained from the helical
domains of the proline mutant when compared to the native
sequence (cf. this work and reference (30). Therefore, the
high-resolution structure and topology determined in this
work for oriented POPC membranes are relevant also for
other phospholipid membranes. Although the novel experi-
mental approach and the data that led to the huntingtin 1–17
structure, topology, and dynamics are presented here for the
first time, we have already used some of the structural coor-
dinates to analyze these and previous data (30) in a consis-
tent manner. Furthermore, in this work the structural and
topological details of huntingtin 1–17 will be discussed in
the context of regulatory posttranslational modifications
and compared to other F-actin binding sequences and
nuclear localization signals. Finally, the structure, topology,
and dynamics of bilayer-associated huntingtin 1–17 may
have important implications for the aggregation of the
neighboring polyglutamine tract.MATERIALS AND METHODS
Deuterated TFE (d3) was purchased from Sigma Aldrich (Steinheim,
Germany). Deuterated DPC (d38) was from Cambridge Isotope Labora-
tories (Andover, MA). Amino-acid derivatives and other reagents for
peptide synthesis were from Novabiochem-Merck (Darmstadt, Germany).
All lipids were purchased from Avanti Polar Lipids (Alabaster, AL).Peptide synthesis of specifically labeled
huntingtin 1–17 peptides
The peptides [15N-Phe11]-huntingtin 1–17, [15N-Leu7, 2H3-Ala
10]-hun-
tingtin 1–17, and [15N-Phe17, 2H3-Ala
2]-huntingtin 1–17 were prepared
by automated solid-phase peptide synthesis using a Millipore 9050 synthe-
sizer, the Fmoc (9-fluorenylmethyloxycarbonyl) chemistry and purified by
semipreparative HPLC as described previously (36). The sequence of
huntingtin 1–17 is MATLEKLMKAFESLKSF and was prepared with an
amidated carboxy-terminus. Therefore, at neutral pH the peptide carries a
net charge of about þ1. At the positions shown in bold the natural
Huntingtin 1–17 Membrane Structure 701abundance Fmoc-protected amino acid derivatives (Bachem, Heidelberg,
Germany and Applied Biosystems, Weiterstadt, Germany) were replaced
with their isotopically enriched analogs (eurisotope, Paris, France) one or
two at a time. The identity and high purity of the product (>90%) was
confirmed by NMR spectroscopy and MALDI mass spectrometry. After
lyophilisation, the TFA counter ions were exchanged twice in 5% acetate
(v/v). Before functional assays or NMR measurements all peptides were
exposed to HFIP/TFA for disaggregation as described previously (37).CD spectropolarimetry
CD spectropolarimetry was performed in 50 mM sodium phosphate buffer,
75 mM sodium chloride, pH 7.3 following protocols described in (36). The
dilution factor was recalculated after each experiment. Four scans from 250
to 195 nm with a scan speed of 20 nm/min were averaged and the CD signal
of the solvent or buffer was subtracted subsequently. Analysis of spectra
was performed using the spectra analyzer (Jasco, Tokyo, Japan) and the
Origin software (Northhampton, MA). The secondary structure of the
peptide was determined by using the spectral fitting methods CONTIN/
LL, CDSSTR, and SELCON in the CDpro package from which the average
was calculated (38).NMR spectroscopy of huntingtin 1–17 in micellar
environments
For 2D solution NMR analysis the disaggregated peptide was dissolved in
the presence of 100 mM DPC-d38 micelles at a concentration of 0.5 mM in
50 mM sodium phosphate buffer, 0.001% (w/v) sodium azide, 10% (v/v)
D2O pH 6.0. Alternatively, the peptide solution was prepared in 50%
TFE-d3, 40% phosphate buffered saline and 10% D2O (v/v/v). For both
solutions homonuclear (1H-1H) two-dimensional TOCSY and NOESY
spectra were recorded at 298 K on a Bruker Avance NMR spectrometer
operating at a 1H frequency of 600 MHz (Bruker Biospin, Rheinstetten,
Germany) and being equipped with a 5 mm BBI 1H/2H probe head with
z-gradient. The mixing times were 80 ms for TOCSY, and 150 ms and
200 ms for NOESY spectra, respectively. NOESY- and TOCSY-spectra
were collected using gradient pulses and the DIPSI-2 spin lock, respec-
tively, as well as the excitation sculpting technique for water suppression
(39). For experiments with DPC micelles the spectral width was chosen
to be 7212 Hz and 8–16 transients for 512 t1-increments with 4096 complex
data points for each free-induction decay. The spectral width for experi-
ments in TFE was set to 6602 Hz and 512 t1-increments with 8–16 tran-
sients for 2048 complex data points were collected. The relaxation delay
was 2 s in all experiments. Before Fourier transformation, a squared sine
bell function was applied in both dimensions, as well as linear prediction
in t1. All spectra were processed using NMRPIPE/NMRDraw (40) and
analyzed by NMRVIEW (41).Structure calculation
The structure calculations were performed using Xplor-NIH 2.17 (42).
NOE intensities from the 200 ms NOESY spectrum were classified into
strong, medium, and weak, corresponding to upper distance restraints of
2.8, 3.4, and 5.0 A˚, respectively. 200 structures were calculated, starting
from an extended structure, using a simulated annealing protocol with the
topology and parameter sets topallhdg and parallhdg, respectively. During
high temperature dynamics 10,000 steps were taken per cycle at 1000 K
with a subsequent decrease of temperature by 6000 steps in the cooling
step to 100 K and subsequently refined by molecular dynamics in explicit
water (43). Finally, 20 conformers with the lowest energy and no NOE
distance violation >0.5A˚ were calculated to generate the ensemble of the
peptide’s structure. The quality of the ensemble was validated using the
PSVS tool (44). The pairwise root mean-square deviation (RMSD) wascalculated as well as all graphical representations were generated using
the program MOLMOL 2K.2 (45). The average structure of both ensem-
bles, resembling the structure of huntingtin 1–17 in TFE or DPC micelles,
was generated using the average.inp Xplor-NIH script, and subsequently
energy minimized by a final water refinement step. Both coordinate files
of the ensembles are accessible through the Protein Data Base (PDB) data-
base (2LD0 and 2LD2); the chemical shift information is available through
the Biological Magnetic Resonance Bank (BMRB) database, accession nos.
17642 for huntingtin 1–17 in 50% (v/v) TFE or 17644 in the presence of
DPC micelles, respectively.Paramagnetic line broadening experiments
To investigate the topology of huntingtin 1–17 in micelles 0.5 mM
disaggregated peptide and 200 mM DPC-d38 were dissolved in 90%
water/10% (v/v) D2O. Spin-labeled 16-doxyl stearic acid (Sigma Aldrich,
Steinheim, Germany) was solubilized in methanol-d4 and added to the
NMR sample at final concentrations of 1.0 and 3.5 mM. MnCl2 was
dissolved in water, sterilized by filtration, and subsequently added to the
sample at concentrations of 0.2 and 0.5 mM. For all experiments, homo-
nuclear 2D TOCSY spectra at an isotropic mixing time of 60 ms at 313
K were recorded. Reference spectra lacking the spin-labels were recorded
at identical conditions. The line broadening of the fingerprint HN-Ha region
was taken into consideration for data analysis.Solid-state NMR spectroscopy
Samples for solid-state NMR spectroscopy were prepared by dissolving
7 mg of huntingtin 1–17 peptide in 100% formic acid and 105 mg of
POPC lipid in HFIP. Both solutions were mixed and carefully applied
onto 25 ultrathin cover glasses (8  22 mm; Paul Marienfeld GmbH &
Co. KG, Lauda-Ko¨nigshofen, Germany) as described previously (46).
Solid-state NMR spectra were recorded on a Bruker Avance wide-bore
NMR spectrometer operating at 9.4 T. A commercial double-resonance
solid-state NMR probe modified with flattened coils of dimensions 15 
4  9 mm was used (47). Proton-decoupled 15N solid-state NMR spectra
were acquired using a cross-polarization sequence and processed as
described previously (48). NH4Cl (40.0 ppm) was used as an external
reference corresponding to 0 ppm for liquid NH3. An exponential apodiza-
tion function corresponding to a line broadening of 50 Hz was applied
before Fourier transformation.
Deuterium solid-state NMR spectra were recorded using a quadrupolar
echo pulse sequence (49) with parameters detailed in (50). The spectra
were referenced relative to 2H2O (0 Hz). An exponential apodization
function corresponding to a line broadening of 300 Hz was applied before
Fourier transformation.
Proton-decoupled 31P solid-state NMR spectra were recorded using a
(90-t-180-t-acquisition) Hahn echo pulse sequence (51) with phase-
cycling (52). The 1H B1 field was 40 kHz, the 90
 pulse length 2.5 ms,
the echo delay (t) 40 ms, and the spectral width 40 kHz. For acquisition
256 scans of 2048 data points were recorded with a repetition time of
3 s. The spectra were referenced relative to 85% phosphoric acid
(0 ppm). An exponential apodization function corresponding to a line
broadening of 20 Hz was applied before Fourier transformation.Calculation of orientational restraints from
the solid-state NMR spectra
To evaluate the peptide orientations that agree with the experimental
spectra, a coordinate system was defined with the tilt angle being the angle
between the long axis of the helix and the membrane normal, and a pitch
angle between the membrane normal and the line within the arbitrary plane
of peptide helical wheel projection (cf. Fig. 5 d for angle definitions).Biophysical Journal 105(3) 699–710
702 Michalek et al.If not indicated otherwise, the calculations were performed using the 15N
chemical shift main tensor elements (56, 81, 223) ppm (53) and 74 kHz for
the maximum quadrupolar splitting for the alanine 2H3C-group (54),
respectively. By successively changing the tilt and pitch angles of the
peptides (50  50 steps) the three-dimensional topological space was
systematically screened and the corresponding 15N chemical shift and
quadrupolar splitting calculated (50). Wagging and azimuthal fluctuations
were assumed to be independent and were taken into account by averaging
the resonance values on the ensemble of orientations with corresponding
Gaussian distributions. The motional regimes tested here have been shown
previously to best fit the solid-state NMR data of amphipathic helices of
similar dimensions (e.g. (55)). Contour plots (cf. Fig. 5, a–c), mark the
angular restrictions that agree with the experimental results.RESULTS
To find optimal conditions for high-resolution structural
investigations and at the same time to obtain insight into
the secondary structure preferences of the huntingtin 1–17
domain a number of sample conditions were screened using
CD spectroscopy. Whereas in aqueous buffer the peptide
adopts mostly random coil conformations with a helix
content of only 10%, this value increases to ~70% in a
more hydrophobic environment like TFE/water mixtures,
or upon stepwise addition of SDS or DPC detergents to
aqueous buffer (Fig. 1). The critical micelle concentrations
of these detergents are 2 mM and 1 mM, respectively (56).
Notably, the critical micellar concentration of SDS is
strongly dependent on the presence of electrolytes and the
value indicated here represents the experimental conditions
of 50–100 mM salt used in this work.
At modest detergent concentrations the helical content of
huntingtin 1–17 obtained in the presence of DPC or SDS
agrees well with the limiting values obtained upon titration
of phospholipid membranes (30). The molecular structure of
the DPC polar group resembles closely the headgroup
of phosphatidylcholines, a lipid abundant in eukaryotic
membranes. Therefore, the NMR structural analysis was
performed in the presence of DPC and validated in oriented
POPC bilayers where the fatty acyl composition represents
well the hydrophobic thickness and the saturated-unsatu-
rated fatty acyl chain composition of biological membranes.FIGURE 1 CD spectra of 50 mM huntingtin 1–17 in the presence of increasin
a-helix content calculated from the CDPro-package using three different algori
Biophysical Journal 105(3) 699–710NMR structures of huntingtin 1–17 in micellar
environments
To obtain a detailed view on the huntingtin 1–17 structure in
membrane environments the peptide was investigated in the
presence of 100 mM deuterated DPC using 2D 1H/1H-NMR
spectroscopy (Fig. S1, a and b in the Supporting Material).
The CD spectroscopic analysis is indicative that the confor-
mational transition from random coil to helical is complete
at this detergent concentration (Fig. 1 c). The NOE assign-
ment and distance constraints are graphically summarized in
Fig. S1 c and the statistics of the structure calculations in
Table S1. From these experimental data 100 structures
were calculated by simulated annealing, followed by refine-
ment in explicit water and their energies evaluated. Using
standard protocols an averaged structure was obtained
from the 20 lowest energy structures, which was further
energy minimized. In the presence of detergent micelles
huntingtin 1–17 forms an amphipathic a-helix from residue
6 to 17, where the conformation of the first five residues is
characterized by a large RMSD (Fig. 2 a). Notably, within
the helical domain the hydrophobic side chains all orient
toward the core of the DPC membrane when at the same
time the charged residues accumulate on the opposite face.
In a next step the topology of DPC-associated huntingtin
1–17 was investigated by the addition of paramagnetic relax-
ation reagents (Fig. 3). The residual amplitude in the pres-
ence of 0.2 and 0.5 mM of the water soluble Mn2þ ion or
of 1 and 3.5 mM of the hydrophobic 16-doxyl-stearate are
shown in Figs. 3, a and b, respectively. Clearly, the amino-
terminus and hydrophilic side chains of the helical region
are mostly affected by the Mn2þ ions, whereas the hydro-
phobic residues of the helix strongly interact with the doxyl
group deeply buried in the core of the micelles. The helical
oscillation is most obvious when the ratio of the residual
amplitude in the presence of hydrophilic/hydrophobic
quencher is shown (Fig. 3 c). Although these data are only
qualitative in nature, they suggest that the amphipathic hun-
tingtin 1–17 domain localizes along the micellar interface.
For comparison the huntingtin 1–17 structure was
determined in 50% (v/v) TFE in water (Fig. S1, d–f andg amounts of TFE (a), SDS (b), and DPC micelles (c). The insets show the
thms.
FIGURE 2 Three-dimensional structures of huntingtin 1–17 in 100 mM
DPC micelles or TFE/buffer 50/50 (v/v). (a) The ensemble of the 20 best
structures is shown (left) and reveals a more rigid carboxy-terminus for
the conformation of huntingtin 1–17 in the presence of 100 mM DPC
micelles compared to the flexible termini in TFE/buffer 50/50 v/v (b).
The ribbon representation of the averaged structure (center) shows the
a-helical conformation from K6 to F17 in the presence of 100 mM DPC
micelles (a) and from residue E5 to E12 in TFE/buffer 50/50 v/v (b).
Notably in the presence of DPC micelles the hydrophobic side chains are
all oriented along one side of huntingtin 1–17, shown for the electrostatic
surface potential with unipolar, negatively and positively charged amino-
acid residue side chains in white, red, and blue, respectively (right).
FIGURE 3 Paramagnetic line broadening caused by the addition of
Mn2þ (a) or 16-doxylstearic acid (b) to 0.5 mM huntingtin 1–17 in
200 mM DPC-d38. The calculation of the quotient of the residual ampli-
tudes (c) indicates that the amino-acid side-chains Leu7, Met8, Ala10, and
Phe11 face the hydrophobic environment of the micelles. In these cases,
the residual amplitude is small in the presence of 16-DSA but elevated in
the presence of Mn2þ. The inverse correlation holds for the hydrophilic
face of the helix. The dotted trace shows a simulated a-helical wave. Where
data points are missing the TOCSY HN-Ha crosspeaks are absent (residues
1–4) or cannot be resolved (residue 14).
Huntingtin 1–17 Membrane Structure 703Table S1). In this environment the helical part of huntingtin
1–17 extends from residues 5 to 12 and the termini exhibit
conformations with high RMSD (Fig. 2 b). Furthermore,
although the Ramanchandran angles of the central residues
occupy the a-helical region the helical pitch is smaller than
in the presence of DPC micelles and ridges of negatively
and positively side chains form parallel to the helix long
axis (Fig. 2 b). Clearly the TFE/water mixture represents
only the average hydrophobicity of the membrane but not
its interfacial properties and, as will be reported below,
already the outlines of the helix disagree with the solid-state
NMR measurements in supported phospholipid bilayers. On
the other hand, the DPC membranes provide a membrane
system mimicking quite well the interface of a phosphati-
dylcholine membrane, when at the same time being acces-
sible to solution NMR techniques. However, also for this
micellar system differences persist when its curvature and
molecular packing are compared to phospholipid bilayers.
Therefore, it is important that the micellar data are validated
in bilayer environments. Consequently, we tested if the
solid-state NMR orientational restraints, which were ob-tained from the selectively labeled sites of huntingtin
1–17, agree with the structural coordinates that result from
the NMR analysis in DPC micellar environments.Topological and structural analysis of
bilayer-associated huntingtin 1–17 by oriented
solid-state NMR spectroscopy
To gain insight into the interactions of huntingtin 1–17 with
phospholipid bilayers several polypeptide sequences wereBiophysical Journal 105(3) 699–710
704 Michalek et al.prepared by solid-phase peptide synthesis and reconstituted
into uniaxially oriented POPC phospholipid bilayers. To
perform a topological and structural analysis of huntingtin
1–17 a labeling scheme was applied, where selected posi-
tions were enriched close to 100% with 15N or 2H isotopes.
Three different types of solid-state NMR spectra were
recorded from these samples (Fig. 4). First, due to the
unique properties of the 15N amide chemical shift tensor,
15N chemical shift measurement of backbone-labeled poly-
peptides provide a direct measure of the approximate tilt
angle of the helical domain (57). Whereas transmembrane
helical alignments are characterized by 15N chemical shifts
in the 200 ppm region, peptides that orient along the
membrane surface exhibit values <100 ppm. Second,FIGURE 4 Proton-decoupled 15N- (a–f) as well as 2H quadrupolar-echo
solid-state NMR spectra (g and h) of 2.5 mol % huntingtin 1–17 peptides
reconstituted into uniaxially oriented POPC bilayers. Huntingtin 1–17
was labeled with 15N at position Phe17 (a,b), Phe11 (c,d), Leu7 (e,f), or
with 2H3 at Ala
10 (g,h). The glass plate normal was aligned parallel (a, c,
e, g) or perpendicular to Bo (b, d, f, h), as illustrated on the top of each
column. Panel g also shows a spectral simulation for a sample mosaicity
with Gaussian distribution of 3. The line broadening applied during this
simulation of the 2H spectrum was 1.5 kHz.
Biophysical Journal 105(3) 699–710when combined with 2H solid-state NMR investigations of
methyl deuterated alanines accurate rotational pitch and
tilt angle information is obtained (33,50). Alternatively,
the helical tilt and rotational pitch angles of helical peptides
have been established from a series of deuterated alanines
(55,58). In addition, oriented solid-state NMR measure-
ments test if residues that are part of the helical structure
in DPC micelles remain helical also in planar lipid bilayers,
because highly mobile (random coil) regions resonate at the
isotropic chemical shift positions and in the case of 15N are
also characterized by inefficient cross-polarization (59).
Third, the 31P NMR spectra of these samples are an indica-
tor of the alignment of the phospholipid headgroup as well
as the membrane macroscopic phase properties (60) and
such control experiments were systematically recorded
from all samples.
Fig. 4, a, c, and e, shows proton-decoupled 15N solid-state
NMR spectra of huntingtin 1–17 labeled with 15N at Phe17
(Fig. 4 a), Phe11 (Fig. 4 c), and Leu7 (Fig. 4 e) with aniso-
tropic 15N chemical shifts of 88.2 5 0.9 ppm, 78.9 5
1.5 ppm, and 71.2 5 1.7 ppm, respectively. The data indi-
cate a nearly perpendicular orientation of the 15N-1H amide
bonds relative to the bilayer normal, and consequently, an
alignment of the peptide helix parallel to the membrane
surface (33). The solid-state NMR data are indicative of
an interfacial localization of huntingtin 1–17 in POPC
bilayers, similar to the one that has been observed in DPC
micelles (Fig. 3). The 2H NMR spectrum shown in
Fig. 4 g exhibits a quadrupolar splitting of 11 kHz, a value
that aligns the Ca–Cb bond of Ala
10 at an instantaneous
angle of either 49 or 61 relative to the bilayer normal
(depending on the sign of the quadrupolar splitting). In
contrast, a much smaller quadrupolar interaction is observed
for 2H3-Ala
2 (not shown) in agreement with the nonhelical
structure observed for the most amino-terminal residues in
DPC micelles (Fig. 2 a). Therefore, the spectra of the 15N
and the 2H3-Ala
10 labeled sites show a well-structured poly-
peptide in the presence of the lipid bilayer environment even
at the outermost positions of the helical domain (Fig. 4),
suggesting that the helical conformation of residues 6 to
17 found in micellar environments is also present when
huntingtin 1–17 is associated with phospholipid bilayers.
In contrast, the solid-state NMR data obtained in phospho-
lipid bilayers is in disagreement with the helical outlines
observed in the TFE/water environment (residues 5–12;
Fig. 2 b).
The solid-state NMR measurements from the labeled
positions 7, 10, 11, and 17 (Fig. 4, a, c, e, and g), restrict
the possible helix orientations relative to the membrane
normal (33,61). Therefore, these experiments also permit
a more detailed evaluation of structural models of huntingtin
(residues 6–17), including the conformational ensemble
of huntingtin 1–17 found in micellar environments
(Fig. 2 a). The topological analyses shown in Fig. 5, a–c,
illustrate the simulations of the 15N chemical shifts and 2H
FIGURE 5 Angular restrictions obtained from solid-state NMR spectra of huntingtin 1–17 reconstituted in oriented POPC bilayers. (a) The possible align-
ments of the low-energy conformer 3 obtained by solutionNMR in the presence of DPCmicelles, structure calculation, and refinement are represented by their
helical tilt and the rotational pitch angles. The solid black lines represent angular pairs that agree with the experimental 2H quadrupolar splitting obtained from
2H3-Ala-10 (115 2.5 kHz), the
15N chemical shifts of 15N-Leu-7 (red; 71.55 2.5 ppm), 15N-Phe-11 (green; 78.55 3 ppm), and 15N-Phe-17 (blue; 885 1.7
ppm) (cf. Fig. 4, a, c, e, and g). The error bars correspond to the line width at half-height. The tilt/rotational pitch angular pair is circled where all experimental
data agree. In (b) the related analysis performedwith the lowest energy structure 1 and in (c) with the average of the 20 low-energy conformations are depicted.
Peptide dynamics were taken into account bywobblingmotions of the helix (10 Gaussian distribution) as well as pitch angle fluctuations around the helix long
axis (18). (d) Exhibits the pitch angle and tilt angle definitionswith some complimentary views to those depicted in (e) and (f). (e) Structural details of residues
5–17 are shown when viewed from the side or from the carboy-terminus, or (f) when viewed from the membrane interior (left) or the aqueous side (right). The
hydrophobic residues are shown in yellow, alanine in gray, serines in green, glutamates in red, and lysines in blue.
Huntingtin 1–17 Membrane Structure 705quadrupolar splittings of the helical part of the huntingtin
1–17 DPC micellar structure for all possible peptide align-
ments in the membrane. Whenever the calculated and the
experimental values agree (including experimental uncer-
tainties), the combination of tilt and orientational pitch
angles is highlighted in the graph (Fig. 5, a–c). The restric-
tion plots that arise in this manner for three 15N (Leu7,
Phe11, Phe17) and the deuterium labels (Ala10) are outlined
in Fig. 5, a–c, by red, green, blue, and black traces, respec-
tively. To take into account the dynamics of peptides that
interact with liquid disordered bilayers, wagging motionsof the peptide as well as azimuthal movements around the
helix long axis were systematically taken into account
(Figs. 5, a–c, and Fig. S2). The effects of such motions on
the 15N chemical shift anisotropy are presented in Fig. S3.
When the averaged structure of the 20 low-energy confor-
mations (Fig. 2 a) is considered there is no perfect match
with all four solid-state NMR topological constraints
(Fig. 5 c). Notably, the structural models shown in Fig. 2
represent an ensemble of low-energy conformations that
agree with the experimental NMR constraints in micellar
or TFE/water environments. However, solution NMRBiophysical Journal 105(3) 699–710
706 Michalek et al.structures are based on a limited number and precision of
geometrical constraints, and adding complementary infor-
mation from solid-state NMR further refines the conforma-
tional analysis (62). In addition, some of these conformers
are expected to better represent the situation in phospholipid
bilayers, thereby reflecting differences in planarity as well
as the detailed molecular structures when the bilayer is
compared to the curved micellar interfaces. Therefore, we
also tested the agreement with solid-state NMR data of indi-
vidual conformers of the ensemble, where the numbering of
individual structures represents the resulting energy from
the molecular dynamics calculations.
Notably, the lowest energy structure 1, like several others,
does not match well the solid-state NMR orientational
restraints from supported phospholipid bilayers (Fig. 5 b),
but a perfect fit is obtained for conformations 3 or 20 where
all four orientational restraints intersect at tilt/rotational
pitch angles around 103/137 (Fig. 5 a). When taking
into account experimental errors, uncertainties in the tensor
values, or the dynamics of the peptide, the very details of the
topological analysis vary in a narrow range, but importantly,
good agreement between individual structures and all four
solid-state NMR restraints is maintained (cf. Fig. S2 and
Fig. S3). Therefore, of all the models tested the membrane
structure of huntingtin 1–17 is best described by the
conformer 3 where the helical part is oriented at tilt/
rotational pitch angles of 10355/13755. The corre-
sponding structural arrangement of huntingtin 5–17 is illus-
trated in Fig. 5, e and f, and the conformational differences
between structures 1, 3, and 20 are visualized in Fig. S4. By
far the largest deviation was observed for Phe17 when
conformer 1 (no match, Fig. 5 b) and 3 (good match,
Fig. 5 a) are compared to each other and where the align-
ment difference of the NH vector is ~20 (Fig. S4 a).
Fig. S4 and the error estimates from Fig. S2 thereby also
provide an indication of the limited range of alternative
conformational models that can describe the membrane-
structure of huntingtin 1–17.
Additional insight into the structural and dynamic proper-
ties of membrane-associated peptides was obtained when the
same samples used to record the spectra shown in Fig. 4, a, c,
e, and gwere tilted by 90. In such an arrangement the mem-
brane normal is perpendicular to the magnetic field direction
(Bo). Thus, rotational diffusion positions an in-plane ori-
ented helix at any alignment relative to the magnetic field di-
rection, including parallel and perpendicular to Bo and all
possible orientations in between. It is therefore expected
that the resulting NMR spectra exhibit a broad assembly of
resonances where all orientations are represented and add
up to a circular powder pattern line shape (63). However, if
rotational diffusion is fast when compared to the 15N chem-
ical shift anisotropy or the 2H quadrupolar interactions,
respectively, an averaged spectrum is obtained.
The proton-decoupled 15N solid-state NMR spectrum of
the 15N labeled amide at position 17 at a 90-sample align-Biophysical Journal 105(3) 699–710ment shows a single 15N resonance at 138 ppm (Fig. 4 b),
which indicates that the peptide diffuses fast around the
membrane normal when compared to the 104 s timescale
of the 15N chemical shift anisotropy. The latter covers a
range from ~60 to 230 ppm (53), which is almost two orders
of magnitude increased when compared to the line width at
half-height of the observed resonance (53 ppm). Notably,
the chemical shift value of the tilted sample confirms the
in-plane alignment of the helical domain (57,64). When
the amide position of Leu7 was investigated in the tilted
arrangement a 15N chemical shift of 144 ppm was observed
(Fig. 4 f), which is indicative of fast rotational averaging
around the membrane normal also for this position. A
related behavior was also found for 15N-Phe11 (138 ppm,
Fig. 4 d). The chemical shift positions obtained from the
0 and 90 aligned samples allow one to calculate the
isotropic chemical shift positions one by one from the three
15N labeled sites. They are all within 120 5 2 ppm sug-
gesting that the wide range of tensor variations taken into
account for the calculation of systematic errors (Fig. S2)
also cover the differences between individual sites.
Fast rotational averaging at even faster timescales
becomes obvious when the [2H3-Ala
10]-huntingtin 1–17
peptide was investigated by deuterium solid-state NMR
spectroscopy (Fig. 4 h). In the case of the 2H3-alanine label
a reduction of the quadrupolar splitting by 1/2 is in
agreement with fast motional averaging around the mem-
brane normal at an order of magnitude decreased timescale
(105 s) (63).DISCUSSION
Despite intensive research and although the hereditary
modifications of huntingtin have been clearly identified
and correlated with Huntington’s disease (65) the biological
function and the molecular mechanisms of how the patho-
genesis develops remain obscure. On the one hand, this is
due to the large number of interaction partners of this pro-
tein and the lack of high-resolution structural information.
On the other hand, the situation is further complicated by
the localization of huntingtin in a great number of organelles
including the cytoplasm, the nucleus, the plasma membrane,
ER, Golgi apparatus, endocytic vesicles, and mitochondria
(5–7,9,26,66,67), which makes the unambiguous identi-
fication of the biological functions of huntingtin or of the
disease-promoting biochemical processes difficult.
The amino-terminal domain of huntingtin encompassing
the first 17 amino acids (huntingtin 1–17) has proven tightly
linked to polyglutamine aggregation and the resulting
toxicity of the protein (7,9,22,29). In this work, we show
that huntingtin 1–17 is capable of undergoing a structural
transition from random coil in aqueous solution to a-helical
conformations in the presence of micelles or isotropic
membrane-mimetic solvents (Figs. 1 and 2). Notably,
the increase in helicity saturates at modest detergent
Huntingtin 1–17 Membrane Structure 707concentrations of 1–4 mM or reaches similarly high values
at TFE concentrations of as little as 17% (v/v) suggesting
that a nucleation core for the structural transition exists
already in aqueous solution (20–22). Consequently, only a
small energetic barrier needs to be overcome during the
structural transitions (Fig. 1). Indeed, helix forming propen-
sities have become evident also in aqueous solution by CD-
(Fig. 1 and (9)) and solution NMR spectroscopies where
transient helical conformations have been detected
involving residues 5 to 7 (22), in molecular dynamics sim-
ulations (21) as well as in the x-ray crystallographic analysis
of a MBP-huntingtin 1–17-polyglutamine fusion protein
(68). The biological relevance of the a-helical conformation
of huntingtin 1–17 is strengthened further by the results of
mutagenesis experiments (9).
In the past the high curvature of micellar systems has
been thought to be responsible for subtle conformational
alterations, especially at the termini of peptides (cf. e.g.
(69)). It is therefore interesting to note that the solid-state
NMR data obtained in POPC bilayers agree with a high
mobility of the amino-terminus (not shown), and confirm
the participation of residues 7, 10, 11, and 17 in the a-helical
domain (Fig. 4). The solid-state and solution NMR data also
agree well with the CD line shape analysis of huntingtin
1–17 where up to ~70% of the peptides adopt helical confor-
mations in the presence of lipid bilayers (30) or in the pres-
ence of detergent micelles (Fig. 1). Notably, the solid-state
NMR topological analysis confirms a a-helical structure at
position 7, i.e., close to the first helical residue in micellar
environments, and of the very carboxy-terminal amino
acid (Fig. 4, a and e). This carboxy-terminal helical con-
formation is probably stabilized by interactions between
the negative end of the helix dipole and the lysine at position
15, similar to previous observations made with other
polypeptides (e.g. (70)).
Furthermore, by comparing the solution and solid-state
NMR data in detail it is possible to select a small subset
of conformations from the solution NMR conformational
ensemble that fits best the orientational restraints derived
from supported bilayers. It should be emphasized that the
high-resolution NMR structure of huntingtin 1–17 (Fig. 2
a) is of similar quality than those obtained for other peptides
of similar size in micellar environments. However, the
solid-state NMR approach has been shown to be a sensitive
indicator of angular deviations, which under favorable con-
ditions can detect differences as small as 1 (33,50). There-
fore, perfect agreement between multiple orientational
restraints requires a coordinate file that closely matches
the bilayer structure (cf. Fig. S4), and combining both
NMR approaches results in a much refined structural
analysis.
The ensemble of data presented in this work indicates that
when bound to lipid bilayers huntingtin 1–17 adopts an
amphipathic helical structure encompassing residues 6 to
17 and that this helical domain is oriented at 10355/13755 (tilt/pitch angles), i.e., close to parallel to the
membrane surface (Fig. 5 a). Oriented solid-state NMR
spectroscopy indicates that similar alignments of the P-hun-
tingtin 1–17 helical domain are obtained in POPE/POPG 3:1
or POPC/POPS 3:1 membranes (30). Therefore, the struc-
tural results presented here appear valid also for other phos-
pholipid membranes. Moreover, the solution NMR structure
(Fig. 2 a) and its topology observed by paramagnetic relax-
ation experiments in micellar environments (Fig. 3) are in
good agreement with the precise bilayer topology deter-
mined by solid-state NMR spectroscopy (Fig. 5 a).
These structural and topological details have important
implications for some of the biological activities that have
been associated with huntingtin and with the amino-termi-
nal domain in particular. First, posttranslational modifica-
tions within huntingtin 1–17 have been identified and
these have important regulatory effects on the activities
and cellular localization of the protein (71,72). The
amino-terminal domain encompasses residues T3, S13,
and S16, which can be phosphorylated, as well as three
lysines and the amino-terminus that can be acetylated, ubiq-
uitinated, or SUMOylated. In membrane-associated hun-
tingtin 1–17 all of these sites but K16 are exposed to the
aqueous phase (Fig. 5 e). Indeed, SUMOylation occurs pref-
erentially at positions 6 and 9 and much less at position 16
(72). In a related manner polyubiquitination of huntingtin
1–17 is favored by introducing a negative charge at serine
13 either by S13D mutagenesis or by phosphorylation
(72). Whereas changing the amino-acid composition and
charge at this position can modulate enzymatic activities,
such modifications have also been shown to decrease the
membrane-association of huntingtin 1–17 (C. Aisenbrey
and B. Bechinger, unpublished; H. Lashuel, personal
communication), which in turn increases the enzymatic
accessibility of ubiquitination sites (72). Furthermore,
such modifications result in the accumulation of the protein
inside the nucleus (28,71,73).
Second, recently a nuclear export signal was identified
encompassing L4, L7, F11, and L14 of huntingtin (17,18).
These form a well-defined hydrophobic ridge in our struc-
ture (cf. Fig. 5 f) and are essential for NES activity. This
is in contrast to a number of residues on the hydrophilic sur-
face (T3, K6, K9, S13, or S16), which in the presence of L4
do not affect the NES activity (9,18). However, in an L4A
mutant the hydrophobic contribution can be restored by
S16L suggesting that interaction with exportin also involves
this residue (17). Indeed, within the structural variety of
leucine-rich nuclear export signals helix or helix-loop con-
formations (Fig. S5) have been found in relative abundance
in the context of the ternary nuclear export complexes of ex-
portin/CRM1 and Ran-GTP (74). Therefore, the membrane
conformation of huntingtin 1–17 comes close to fit the
hydrophobic pocket of the binding site but probably requires
some conformational alternations at the carboxy-terminal
region to better position S16 (Fig. 5, e and f, and Fig. S5).Biophysical Journal 105(3) 699–710
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of huntingtin 1–17 occludes its NES interactions site
(Fig. 5, e and f), and thereby contributes to the regulation
of huntingtin localization and activity.
Third, huntingtin 1–14 has been identified to interact with
F-actin at 2 mM affinity (13). We have therefore compared
the structures of other known F-actin binders with that of
huntingtin 1–17. Indeed, gelsolin has the capacity to bind
F-actin and to form an amphipathic helix with properties
related to the huntingtin 1–17 structure (Fig. S5).
Finally, the amphipathic helical conformation of hunting-
tin 6–17 (Figs. 2 a and 5) assures the reversible interaction
of the protein with biological membranes and thereby re-
sults in a high local concentration of the polyglutamines at
the membrane surface. Thus, membrane association poten-
tially enhances protein-protein interactions and aggregation.
In this context it is important to note that docking experi-
ments using the DOT 2.0 software (75) reveal the potential
of huntingtin 6–17 to associate into antiparallel helical
dimers where residues K9-E12, and K6-S16 from different
polypeptide chains face each other (not shown). Further-
more, the structural details in conjunction with the topolog-
ical arrangement of huntingtin 1–17 indicate that its very
carboxy-terminus is located at the membrane interface
(Fig. 5, e and f), thus that the polyglutamines can remain
in contact with the water phase and interact with each other.
Additional domains for membrane interaction of hunting-
tin have been identified in a region proximal to residues
229–249 (76). This site is further apart from the poly-
glutamine tract and can reinforce the membrane association
of huntingtin by electrostatic interactions. Furthermore, a
recent publication indicates that amyloidogenesis of
huntingtin can be further enhanced by residues 105–138
localized downstream of the polyglutamine domain (77).
Upon fibril formation the polyglutamine tract undergoes a
transition into a b-strand conformation (78,79), when at the
same time much of the a-helical conformation of huntingtin
1–17 persists (79). This observation is suggestive that the
increase in polyglutamine aggregation due to the presence
of the huntingtin 1–17 domain (7,9,20–22) is a result of
accelerated aggregation kinetics and/or a stabilization of
aggregation intermediates (80) rather than of differences
in the structure of the polyglutamine fibrils that ultimately
form. Therefore, during the formation of polyglutamine
oligomers the helical domain may fulfill two functions,
namely anchoring huntingtin to the membrane thereby
serving as a nucleation scaffold for the aggregation
process (20).CONCLUSIONS
By combining 2D solution and solid-state NMR spectros-
copies, we determined the structure and topology of the
huntingtin amino-terminal domain in membranes. The poly-
peptide adopts an amphipathic a-helical structure betweenBiophysical Journal 105(3) 699–710residues 6 and 17, i.e., right to the start of the polyglutamine
tract. The helix is oriented close to parallel to the membrane
surface (at an angle of ~13) and can thereby act as a revers-
ible membrane anchor for huntingtin. Furthermore, this
amphipathic helix has the potential to interact with its likes
or with other proteins where mutagenesis has identified the
huntingtin amino-terminus as a key element. Therefore, the
formation of an amphipathic helical structure can have
important consequences for the regulation of the biological
activities of this protein as well as the development of
Huntington’s disease.SUPPORTING MATERIAL
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